GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bellicum Pharmaceuticals Inc (FRA:BPXA) » Definitions » Receivables Turnover

Bellicum Pharmaceuticals (FRA:BPXA) Receivables Turnover : 66.93 (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Bellicum Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Bellicum Pharmaceuticals's Revenue for the three months ended in Sep. 2023 was €0.94 Mil. Bellicum Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2023 was €0.01 Mil. Hence, Bellicum Pharmaceuticals's Receivables Turnover for the three months ended in Sep. 2023 was 66.93.


Bellicum Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Bellicum Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bellicum Pharmaceuticals Receivables Turnover Chart

Bellicum Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.84 11.99 2.99 59.97 7.82

Bellicum Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 0.47 1.00 - 66.93

Competitive Comparison of Bellicum Pharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, Bellicum Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bellicum Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bellicum Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Bellicum Pharmaceuticals's Receivables Turnover falls into.



Bellicum Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Bellicum Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

Receivables Turnover (A: Dec. 2022 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2022 ) / ((Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count )
=1.416 / ((0.181 + 0) / 1 )
=1.416 / 0.181
=7.82

Bellicum Pharmaceuticals's Receivables Turnover for the quarter that ended in Sep. 2023 is calculated as

Receivables Turnover (Q: Sep. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2023 ) / ((Accounts Receivable (Q: Jun. 2023 ) + Accounts Receivable (Q: Sep. 2023 )) / count )
=0.937 / ((0 + 0.014) / 1 )
=0.937 / 0.014
=66.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bellicum Pharmaceuticals  (FRA:BPXA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Bellicum Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Bellicum Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Bellicum Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
3730 Kirby Drive, Suite 1200, Houston, TX, USA, 77098
Bellicum Pharmaceuticals Inc is a biopharmaceutical company that has discovered and developed novel, controllable cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors. its proprietary Chemical Induction of Dimerization technology platform is designed to enable control of components of the immune system in real-time. Its product candidates are; BPX-601 an autologous GoCAR-T product candidate designed to treat solid tumors expressing prostate stem cell antigen, or PSCA, and BPX-603 an autologous dual-switch GoCAR-T product candidate designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen, or HER2.

Bellicum Pharmaceuticals Headlines

No Headlines